Tremblay K - Search Results

1

Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.

Gaudet D, de Wal J, Tremblay K, Déry S, van Deventer S, Freidig A, Brisson D, Méthot J. Gaudet D, et al. Among authors: tremblay k. Atheroscler Suppl. 2010 Jun;11(1):55-60. doi: 10.1016/j.atherosclerosissup.2010.03.004. Epub 2010 Apr 27. Atheroscler Suppl. 2010. PMID: 20427244 Review.

2

Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics.

Brisson D, Méthot J, Tremblay K, Tremblay M, Perron P, Gaudet D. Brisson D, et al. Among authors: tremblay k, tremblay m. Pharmacogenet Genomics. 2010 Dec;20(12):742-7. doi: 10.1097/FPC.0b013e328340095e. Pharmacogenet Genomics. 2010. PMID: 21217359

3

Contribution of adiponectin to the cardiometabolic risk of postmenopausal women with loss-of-function lipoprotein lipase gene mutations.

Loucif Y, Méthot J, Tremblay K, Brisson D, Gaudet D. Loucif Y, et al. Among authors: tremblay k. Menopause. 2011 May;18(5):558-62. doi: 10.1097/gme.0b013e3181fca1d4. Menopause. 2011. PMID: 21252727

4

Etiology and risk of lactescent plasma and severe hypertriglyceridemia.

Tremblay K, Méthot J, Brisson D, Gaudet D. Tremblay K, et al. J Clin Lipidol. 2011 Jan-Feb;5(1):37-44. doi: 10.1016/j.jacl.2010.11.004. Epub 2010 Nov 18. J Clin Lipidol. 2011. PMID: 21262505

5

Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial.

Gaudet D, Méthot J, Déry S, Brisson D, Essiembre C, Tremblay G, Tremblay K, de Wal J, Twisk J, van den Bulk N, Sier-Ferreira V, van Deventer S. Gaudet D, et al. Among authors: tremblay g, tremblay k. Gene Ther. 2013 Apr;20(4):361-9. doi: 10.1038/gt.2012.43. Epub 2012 Jun 21. Gene Ther. 2013. PMID: 22717743 Free PMC article. Clinical Trial.

6

Medical resource use and costs associated with chylomicronemia.

Gaudet D, Signorovitch J, Swallow E, Fan L, Tremblay K, Brisson D, Meyers C, Gruenberger JB. Gaudet D, et al. Among authors: tremblay k. J Med Econ. 2013;16(5):657-66. doi: 10.3111/13696998.2013.779277. Epub 2013 Mar 11. J Med Econ. 2013. PMID: 23428107 Free article.

7

Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency.

Tremblay K, Dubois-Bouchard C, Brisson D, Gaudet D. Tremblay K, et al. Front Genet. 2014 Apr 22;5:90. doi: 10.3389/fgene.2014.00090. eCollection 2014. Front Genet. 2014. PMID: 24795752 Free PMC article.

8

Targeting APOC3 in the familial chylomicronemia syndrome.

Gaudet D, Brisson D, Tremblay K, Alexander VJ, Singleton W, Hughes SG, Geary RS, Baker BF, Graham MJ, Crooke RM, Witztum JL. Gaudet D, et al. Among authors: tremblay k. N Engl J Med. 2014 Dec 4;371(23):2200-6. doi: 10.1056/NEJMoa1400284. N Engl J Med. 2014. PMID: 25470695 Free article.

9

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome.

Meyers CD, Tremblay K, Amer A, Chen J, Jiang L, Gaudet D. Meyers CD, et al. Among authors: tremblay k. Lipids Health Dis. 2015 Feb 18;14:8. doi: 10.1186/s12944-015-0006-5. Lipids Health Dis. 2015. PMID: 25889044 Free PMC article. Clinical Trial.

10

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.

Gaudet D, Alexander VJ, Baker BF, Brisson D, Tremblay K, Singleton W, Geary RS, Hughes SG, Viney NJ, Graham MJ, Crooke RM, Witztum JL, Brunzell JD, Kastelein JJ. Gaudet D, et al. Among authors: tremblay k. N Engl J Med. 2015 Jul 30;373(5):438-47. doi: 10.1056/NEJMoa1400283. N Engl J Med. 2015. PMID: 26222559 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page